ARTICLE | Company News
Dura infectious diseases news
May 3, 1999 7:00 AM UTC
DURA formed an acute care division to market Maxipeme cefepime and Azactam aztreonam injectable hospital anti-infectives, which DURA licensed from Bristol-Myers Squibb Co. (Princeton, N.J.) in 1998 ...